Related references
Note: Only part of the references are listed.Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2014)
Topical therapy is underused in patients with ulcerative colitis
F. Seibold et al.
JOURNAL OF CROHNS & COLITIS (2014)
Proximal disease extension and related predicting factors in ulcerative proctitis
Bun Kim et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)
Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients
K. J. Schmidt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - a placebo-controlled study
M. Watanabe et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Systematic review: the efficacy of herbal therapy in inflammatory bowel disease
S. C. Ng et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
5-Aminosalicylic Acid and Chemoprevention: Does It Work?
Anthony Lopez et al.
DIGESTIVE DISEASES (2013)
Clinical Course of Cuffitis in Ulcerative Colitis Patients with Restorative Proctocolectomy and Ileal Pouch-Anal Anastomoses
Bin Wu et al.
INFLAMMATORY BOWEL DISEASES (2013)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2013)
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Brian G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The long-term efficacy of azathioprine in steroid-dependent ulcerative colitis
Soo-Kyung Park et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study
J. M. Richter et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies
Tine Jess et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Appendicectomy as a potential therapy for refractory ulcerative proctitis
S. Bageacu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
A Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Mesalamine Suppositories 1 g at Bedtime and 500 mg Twice Daily in Patients with Active Mild-to-Moderate Ulcerative Proctitis
Mark Lamet
DIGESTIVE DISEASES AND SCIENCES (2011)
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial
Walter Reinisch et al.
GUT (2011)
Infliximab for refractory ulcerative proctitis
G. Bouguen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Clinical Trial: A Novel High-dose 1 g Mesalamine Suppository (Salofalk) Once Daily Is as Efficacious as a 500-mg Suppository Thrice Daily in Active Ulcerative Proctitis
Tilo Andus et al.
INFLAMMATORY BOWEL DISEASES (2010)
Topically Administered Infliximab Can Work in Ulcerative Proctitis Despite the Ineffectiveness of Intravenous Induction Therapy
Tamas Molnar et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Appendicectomy as a Therapy for Ulcerative Proctitis
Terry Dorcen Bolin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis
Axel U. Dignass et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2009)
Therapeutic Strategies for the Management of Ulcerative Colitis
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2009)
Local Application of Tacrolimus in Distal Colitis: Feasible and Safe
Jolanda M. van Dieren et al.
INFLAMMATORY BOWEL DISEASES (2009)
Rectal tacrolimus in the treatment of resistant ulcerative proctitis
I. C. Lawrance et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Mesalamine Foam Enema Versus Mesalamine Liquid Enema in Active Left-Sided Ulcerative Colitis
Antoine Cortot et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared with 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial
Stephen B. Hanauer et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Nonadherence in inflammatory bowel disease:: Results of factor analysis
Petr Cerveny et al.
INFLAMMATORY BOWEL DISEASES (2007)
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis:: A multicenter, randomized, double-blind study
L. Biancone et al.
DIGESTIVE AND LIVER DISEASE (2007)
Ulcerative colitis and clinical course: Results of a 5-year population-based follow-up study (The IBSEN study)
Magne Henriksen et al.
INFLAMMATORY BOWEL DISEASES (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence
P. Desreumaux et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
S Ardizzone et al.
GUT (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Efficacy of rebamipide enemas in active distal ulcerative colitis and proctitis: A prospective study report
K Makiyama et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Curcumin therapy in inflammatory bowel disease: A pilot study
PR Holt et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: The ASCEND II trial
SB Hanauer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis
M Brunner et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Treatment of rectal cuff inflammation (Cuffitis) in patients with ulcerative colitis following restorative proctocolectomy and ileal pouch-anal anastomosis
B Shen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Oral mesalazine (5-ASA) treatment may protect against proximal extension of mucosal inflammation in ulcerative proctitis
R Pica et al.
INFLAMMATORY BOWEL DISEASES (2004)
Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis
A Sinha et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Share Paper
